×
Back to IndieWire

Fujifilm, Camera and Film Giant, Is Leading Japan’s Fight to Cure Coronavirus

A subsidiary of the Japanese photography and imaging company is behind an antiviral pill being used to treat COVID-19 in Japan and Turkey.

Office workers wearing protective masks to avoid infection from the coronavirus walk to their offices after taking overcrowded commuter trains, at a railway station in central Tokyo, Japan, 06 April 2020. Japanese Prime Minister Shinzo Abe is expected to declare the state of emergency on 07 April 2020 over the COVID-19 and coronavirus outbreak.Office workers commute to their offices during coronavirus pandemic, Tokyo, Japan - 06 Apr 2020

Office workers at a railway station in Tokyo, Japan

KIMIMASA MAYAMA/EPA-EFE/Shutterstock

The race to find a cure for the novel coronavirus is getting major assistance in Japan from Fujifilm, the global photography and imaging company based in Tokyo. A new report from Wired states that a team of Fujifilm employees was tasked by Japan’s health minister, Katsunobu Kato, to find an antiviral pill that could be used to help fight COVID-19 symptoms. The Fujifilm team turned to Favipiravir, a version of an anti-influenza drug called Avigan (the Fujifilm subsidiary Toyama Chemical developed Avigan decades ago). According to Wired, Favipiravir was previously used to cut the Ebola rate in Guinea from 30 percent to 15 percent.

Beginning March 28, Japan’s prime minster Shinzo Abe “designated Avigan as Japan’s standard treatment for COVID-19.” According to Wired’s report, “At a hospital in Shenzhen, COVID-19 patients treated with Favipiravir tested negative for the virus after a median of four days, rather than the 11 days it took for members of the study’s control group to test negative; in another study carried out in Wuhan, patients taking the drug allegedly recovered from fever nearly two days earlier than those who did not take the medication.”

Japan is now relying on Favipiravir to help fight COVID-19, as are countries such as Turkey. The antiviral pill works “by inhibiting the replication of viral genes within infected cells, thereby mitigating the virus’ ability to spread from one cell to another.” The Fujifilm team is in the middle of a clinical trial using the antiviral pill that will conclude in June.

The hope is that the drug will prevent COVID-19 patients with low viral loads from getting any sicker. Japan’s prime minster announced last weekend the country will “start to boost production and proceed with clinical research in cooperation with those countries that wish to join us.”

Unlike the majority of the world, Japan hasn’t seen an explosion in COVID-19 cases and deaths. As of April 3, there have been 2,617 reported cases of the disease in the country and only 61 deaths. Fujimfilm team members told Wired that Indonesia is one of several counties contacting them and expressing interest in using Favipiravir to fight COVID-19, but the company “declined to name them [all the countries] and won’t say how much of the drug they will be exporting.”

Head over to Wired’s website to read more about Fujifilm’s fight to cure coronavirus.

Sign Up: Stay on top of the latest breaking film and TV news! Sign up for our Email Newsletters here.

This Article is related to: Film and tagged , ,


Get The Latest IndieWire Alerts And Newsletters Delivered Directly To Your Inbox